Anca Pamfil
Pediatric Endocrinology · Plano, TXNPI 1992195028
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $783 and has fallen 95.6% since, to $35 in 2025.
Across 118 payments — averaging $21.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascendis Pharma Endocrinology Inc$523
- Novo Nordisk$516
- AbbVie$305
- Dexcom, Inc.$185
- Insulet Corporation$108
- Tolmar Pharmaceuticals, Inc.$84
- plus $775 from 16 others
What the payments were for
- Food & beverage$2,46499%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 18 | $523 |
| Novo Nordisk | 25 | $516 |
| AbbVie | 18 | $305 |
| Dexcom, Inc. | 10 | $185 |
| Insulet Corporation | 7 | $108 |
| Tolmar Pharmaceuticals, Inc. | 4 | $84 |
| AstraZeneca | 3 | $82 |
| Biomarin Pharmaceutical Inc. | 3 | $76 |
| Kyowa Kirin, Inc. | 3 | $73 |
| Rhythm Pharmaceuticals, Inc. | 3 | $69 |
| Tandem Diabetes Care, Inc. | 3 | $67 |
| Tolmar, Inc. | 3 | $64 |
| Ipsen Biopharmaceuticals, Inc | 3 | $51 |
| Eton Pharmaceuticals, Inc. | 2 | $47 |
| Pfizer | 3 | $45 |
| Abbott | 2 | $40 |
| Neurocrine Biosciences, Inc. | 1 | $35 |
| Ferring Pharmaceuticals Inc. | 2 | $30 |
| IBSA Pharma Inc. | 2 | $28 |
| Medtronic | 1 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| BETA Bionics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SKYTROFA$109
How this compares
$2,496 in reported general payments places this provider in the 70th percentile of 120 pediatric endocrinology providers in Texas.
Other pediatric endocrinology in Plano
- Amy BurtonPlano$130K
- Jose Gamez-GodoyEdinburg$207K
- Virginia AraizaHouston$151K
- Daniel DesalvoHouston$133K
- Susan NunezAustin$91K
- Hector GranadosEl Paso$73K
- Donnie WilsonFort Worth$58K
- Paul ThorntonFort Worth$52K
- Jane LynchSan Antonio$44K
- Steven WaguespackHouston$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.